Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
eli lilly
3
×
fda
glaxosmithkline
3
×
indiana blog main
indiana top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
biogen
cancer
chinook therapeutics
deals
duchenne muscular dystrophy
genentech
What
bio
3
×
roundup
days
drugs
alliance
appetite
august
biotech
black
bread
bristol
busy
butter
buy
buyout
calls
cancer
cash
changing
color
crispr
decisions
devices
diabetes
diamond’s
eli
fda
giant
grabbed
growing
hasn’t
hold
hours
kudos
leaves
legacy
lilly's
lost
loxo
myers’s
Language
unset
Current search:
glaxosmithkline
×
bio
×
national
×
amgen
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More